Developing a plant-based method to remove arsenic from contaminated soil
A novel strategy for arsenic phytoremediation
['FUNDING_R01'] · UNIVERSITY OF MASSACHUSETTS AMHERST · NIH-11001834
This study is testing a special plant that can help clean up arsenic from contaminated soil, which could lead to safer food and a healthier environment for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MASSACHUSETTS AMHERST (nih funded) |
| Locations | 1 site (HADLEY, UNITED STATES) |
| Trial ID | NIH-11001834 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a genetically engineered plant, Crambe abyssinica, to effectively absorb and detoxify arsenic from contaminated land. By utilizing nanosulfur to enhance the plant's ability to extract arsenic, the study aims to develop a cost-effective and environmentally friendly solution to a significant global health issue. The project will involve laboratory, greenhouse, and field evaluations to assess the effectiveness of the engineered plants in removing arsenic from the soil. Patients may benefit from reduced arsenic exposure through improved food safety and environmental health.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals living in areas with known arsenic contamination in soil or water sources.
Not a fit: Patients who are not affected by arsenic contamination or live in areas with safe environmental conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer food sources and reduced health risks associated with arsenic contamination.
How similar studies have performed: Previous research has shown promise in using phytoremediation techniques for heavy metal removal, indicating potential success for this novel approach.
Where this research is happening
HADLEY, UNITED STATES
- UNIVERSITY OF MASSACHUSETTS AMHERST — HADLEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DHANKHER, OM PARKASH — UNIVERSITY OF MASSACHUSETTS AMHERST
- Study coordinator: DHANKHER, OM PARKASH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.